Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Non-autoimmune fulminant type 1 diabetes].

¹Department of Clinical Laboratory Medicine, Wakayama Medical University, Wakayama 641-8509.

Rinsho Byori. the Japanese Journal of Clinical Pathology

|January 19, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with Type 2 diabetes: a long-term follow-up study.

Diabetic medicine : a journal of the British Diabetic Association·2012

Same author

Podocalyxin expression in undifferentiated thyroid carcinomas.

Journal of clinical pathology·2008

Same author

Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2002

Same author

A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese.

Diabetes·2001

Same author

Single nucleotide polymorphism (D68D, T to C) in the syntaxin 1A gene correlates to age at onset and insulin requirement in Type II diabetic patients.

Diabetologia·2001

Same author

The renal metabolism of insulin: urinary insulin excretion in patients with mutant insulin syndrome (insulin Wakayama).

Metabolism: clinical and experimental·2001

Same journal

[The Role of Laboratory Medicine in Hematopoietic Stem Cell Transplantation "Echocardiogram"].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[The Significance of Pulmonary Function Testing Before and After Allogeneic Stem Cell Transplantation].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[Blood Transfusion Inspection].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[The Role of Clinical Laboratory Technicians at Bone Marrow Transplantation : Blood Test].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[The Foundation of Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Clinical Laboratory Tests in This Field].

Rinsho byori. The Japanese journal of clinical pathology·2019

Same journal

[How to Interpret Data from Routine Laboratory Tests].

Rinsho byori. The Japanese journal of clinical pathology·2019

See all related articles

A novel subtype of type 1B diabetes mellitus presents as a non-autoimmune, fulminant disorder. This condition is marked by abrupt onset, absence of insulitis and antibodies, and high pancreatic enzymes.

Area of Science:

Endocrinology
Immunology
Metabolic Disorders

Background:

The Japan Diabetes Association proposed an etiology-based classification for diabetes mellitus in 1999.
Type 1 diabetes was subclassified into type 1A (autoimmune) and type 1B (idiopathic).
Type 1B diabetes is recognized as a heterogeneous group.

Purpose of the Study:

To review and summarize a newly identified subtype of type 1B diabetes mellitus.
To characterize the distinct features of this novel diabetes mellitus subtype.

Main Methods:

Literature review summarizing recent findings on a novel diabetes subtype.
Analysis of clinical characteristics including onset, immunological markers, and biochemical profiles.

Related Experiment Videos

Main Results:

A novel subtype of type 1B diabetes mellitus has been identified.
This subtype is characterized by a non-autoimmune, fulminant disorder.
Key features include absence of insulitis, lack of diabetes-related antibodies, abrupt onset, and elevated serum pancreatic enzymes.

Conclusions:

The newly reported subtype represents a distinct clinical entity within type 1B diabetes mellitus.
This subtype's non-autoimmune, fulminant nature requires specific diagnostic and management considerations.
Further research is needed to fully elucidate the pathophysiology and optimal treatment strategies for this subgroup.